These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6791682)

  • 21. Assessment of the body burden of chelatable lead: a model and its application to lead workers.
    Araki S; Ushio K
    Br J Ind Med; 1982 May; 39(2):157-60. PubMed ID: 6802167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Red cell system and selected red cell enzymes in men occupationally exposed to mercury vapours].
    Zabiński Z; Rutowski J; Moszczyński P; Dabrowski Z
    Przegl Lek; 2006; 63 Suppl 7():74-83. PubMed ID: 17784549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erythrocyte zinc protoporphyrin determination for screening for lead exposure.
    Torrance JD; Mills W; Green A; Kilroe-Smith TA; Smith AN
    S Afr Med J; 1985 May; 67(21):848-50. PubMed ID: 3992423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between the lead concentration in hair and occupational exposure.
    Niculescu T; Dumitru R; Botha V; Alexandrescu R; Manolescu N
    Br J Ind Med; 1983 Feb; 40(1):67-70. PubMed ID: 6824602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Activity of natural fatty acids on erythrocyte osmotic resistance].
    De Caro L; Ghizzi A; Bensi L; Berti P; Minelli R
    Boll Soc Ital Biol Sper; 1991 Sep; 67(9):861-7. PubMed ID: 1810341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of anticoagulants on the activity of gelatinases.
    Castellazzi M; Tamborino C; Fainardi E; Manfrinato MC; Granieri E; Dallocchio F; Bellini T
    Clin Biochem; 2007 Nov; 40(16-17):1272-6. PubMed ID: 17904541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of EDTA samples for prothrombin time measurement in patients receiving oral anticoagulants.
    Horsti J
    Haematologica; 2001 Aug; 86(8):851-5. PubMed ID: 11522542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous insulin immunoassay in sera, heparin-, and EDTA-plasma.
    Balászi I; Stützel M; Littmann L; Láng I
    Rev Roum Med; 1974; 12(3):175-80. PubMed ID: 4218658
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of lead chelation therapy with EDTA in children on erythrocyte pyrimidine 5'-nucleotidase and with cytidine triphosphate levels.
    Swanson MS; Angle CR; Stohs SJ
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):497-500. PubMed ID: 6293983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Erythrocyte zinc protoporphyrin concentration in occupational exposure to lead].
    Stankiewicz A; Frydrych J
    Med Pr; 1982; 33(1-3):25-30. PubMed ID: 7144540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of erythrocyte vitamin B12 activity.
    Santini R; Millán S
    Am J Clin Nutr; 1976 Jul; 29(7):791-3. PubMed ID: 820180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arginase and kallikrein activities as biochemical indices of occupational exposure to lead.
    Chmielnicka J; Komsta-Szumska E; Szymańska JA
    Br J Ind Med; 1981 May; 38(2):175-8. PubMed ID: 6909029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measurement of Type B natriuretic peptide in heparin and K(2) EDTA plasma.
    Daves M; Pusceddu I; Cemin R
    Clin Biochem; 2010 Mar; 43(4-5):483-4. PubMed ID: 19944086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoassay and antibody microarray analysis of the HUPO Plasma Proteome Project reference specimens: systematic variation between sample types and calibration of mass spectrometry data.
    Haab BB; Geierstanger BH; Michailidis G; Vitzthum F; Forrester S; Okon R; Saviranta P; Brinker A; Sorette M; Perlee L; Suresh S; Drwal G; Adkins JN; Omenn GS
    Proteomics; 2005 Aug; 5(13):3278-91. PubMed ID: 16038022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of pyrimidine 5'-nucleotidase (P5N) activity in whole blood as an index of lead exposure.
    Sakai T; Araki T; Ushio K
    Br J Ind Med; 1988 Jun; 45(6):420-5. PubMed ID: 2840110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of increased osmotic resistance of red cells in workers exposed to lead.
    Karai I; Fukumoto K; Horiguchi S
    Br J Ind Med; 1982 May; 39(2):153-6. PubMed ID: 7066232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of anticoagulants on the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities.
    Gerlach RF; Uzuelli JA; Souza-Tarla CD; Tanus-Santos JE
    Anal Biochem; 2005 Sep; 344(1):147-9. PubMed ID: 15950912
    [No Abstract]   [Full Text] [Related]  

  • 38. Determination of plasma lead levels in normal subjects and in lead-exposed workers.
    Cavalleri A; Minoia C; Pozzoli L; Baruffini A
    Br J Ind Med; 1978 Feb; 35(1):21-6. PubMed ID: 629885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma-lead concentration: investigations into its usefulness for biological monitoring of occupational lead exposure.
    Bergdahl IA; Gerhardsson L; Liljelind IE; Nilsson L; Skerfving S
    Am J Ind Med; 2006 Feb; 49(2):93-101. PubMed ID: 16419091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lead-erythrocyte protoporphyrin correlation in blood of exposed workers.
    Peter F; Reynolds RG
    Health Lab Sci; 1978 Jul; 15(3):144-9. PubMed ID: 701012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.